style="font-size:15px;"> 384 384. Emelyanova AI, Mikheeva GA, Ermakova GG. Amniotic fluid immunoglobulins at different dates of pregnancy [in Russian]. Akush Ginekol (Mosk) 1982; 7:19.385 385. Harwick HJ, Iuppa JB, Fekety FR, Jr. Microorganisms and amniotic fluid. Obstet Gynecol 1969; 33:256.
386 386. Tafari N, Ross SM, Naeye RL, et al. Failure of bacterial growth inhibition by amniotic fluid. Am J Obstet Gynecol 1977; 128:187.
387 387. Thadepalli H, Appleman MD, Maidman JE, et al. Antimicrobial effect of amniotic fluid against anaerobic bacteria. Am J Obstet Gynecol 1977; 127:250.
388 388. Walsh H, Hildebrandt RJ, Prystowsky H. Growth inhibition factors in amniotic fluid. Am J Obstet Gynecol 1965; 93:590.
389 389. Sarkany I, Gaylarde CC. The effect of amniotic fluid on bacterial growth. Br J Dermatol 1968; 80:241.
390 390. Gusdon JP. A bactericidin for Bacillus subtilis in pregnancy. J Immunol 1962; 88:494.
391 391. Galask RP, Snyder IS. Bacterial inhibition by amniotic fluid. Am J Obstet Gynecol 1968; 102:949.
392 392. Altieri C, Maruotti G, Natale C, et al. In vitro survival of Listeria monocytogenes in human amniotic fluid. Zentralbl Hyg Umweltmed 1999; 202:377.
393 393. Bratlid D, Lindback T. Bacteriolytic activity of amniotic fluid. Obstet Gynecol 1978; 51:63.
394 394. Schlievert PS, Johnson W, Galask RP. Bacterial growth inhibition by amniotic fluid. VI. Evidence for a zinc peptide antibacterial system. Am J Obstet Gynecol 1976; 125:906.
395 395. Soto E, Espinoza J, Nien JK, et al. Human beta‐defensin‐2: a natural antimicrobial peptide present in amniotic fluid participates in the host response to microbial invasion of the amniotic cavity. J Matern Fetal Neonatal Med 2007; 20:15.
396 396. Thadepalli H, Bach VT, Davidson EC, Jr. Antimicrobial effect of amniotic fluid. Obstet Gynecol 1978; 52:198.
397 397. Kim JY, Park SC, Lee JK, et al. Novel antibacterial activity of beta(2)‐microglobulin in human amniotic fluid. PLoS One 2012; 7:e47642.
398 398. Evaldson G, Nord CE. Amniotic fluid activity against Bacteroides fragilis and group B streptococci. Med Microbiol Immunol 1981; 170:11.
399 399. Ismail MA, Salti GI, Moawad AH. Effect of amniotic fluid on bacterial recovery and growth: clinical implications. Obstet Gynecol Surv 1989; 44:571.
400 400. Martius J, Eschenbach DA. The role of bacterial vaginosis as a cause of amniotic fluid infection, chorioamnionitis and prematurity – a review. Arch Gynecol Obstet 1990; 247:1.
401 401. Farzin A, Boyer P, Ank B, et al. Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro. AIDS Res Hum Retroviruses 2013; 29:77.
402 402. Charles D, Edwards WR. Infectious complications of cervical cerclage. Am J Obstet Gynecol 1981; 141:1065.
403 403. Lebon P, Girard S, Thepot F, et al. Embryologie générale: présence constante d'interféron de type a dans les liquides amniotiques humains. C R Hebd Seances Acad Sci Paris 1981; 293:69.
404 404. Morgan‐Capner P, Rodeck CH, Nicolaides KH, et al. Prenatal detection of rubella‐specific IgM in fetal sera. Prenat Diagn 1985; 5:21.
405 405. Ho‐Terry L, Terry GM, Londesborough P. Diagnosis of foetal rubella virus infection by polymerase chain reaction. J Gen Virol 1990; 71 (Pt 7):1607.
406 406. Bosma TJ, Corbett KM, Eckstein MB, et al. Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol 1995; 33:2881.
407 407. Combs CA, Gravett M, Garite TJ, et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol 2014; 210:125 e1.
408 408. Ardissone AN, de la Cruz DM, Davis‐Richardson AG, et al. Meconium microbiome analysis identifies bacteria correlated with premature birth. PLoS One 2014; 9:e90784.
409 409. Pons JC, Vial P, Rozenberg F, et al. Diagnostic prenatal de la foetopathie varicelleuse au deuxi`eme trimester de la grossesse. [Prenatal diagnosis of fetal varicella in the second trimester of pregnancy]. J Gynecol Obstet Biol Reprod (Paris) 1995; 24:829.
410 410. Dufour P, de Bievre P, Vinatier D, et al. Varicella and pregnancy. Eur J Obstet Gynecol Reprod Biol 1996; 66:119.
411 411. Shukla SK, Meier PR, Mitchell PD, et al. Leptotrichia amnionii sp. nov., a novel bacterium isolated from the amniotic fluid of a woman after intrauterine fetal demise. J Clin Microbiol 2002; 40:3346.
412 412. Blanco JD, Gibbs RS, Krebs LF, et al. The association between the absence of amniotic fluid bacterial inhibitory activity and intra‐amniotic infection. Am J Obstet Gynecol 1982; 143:749.
413 413. Grose C, Weiner CP. Prenatal diagnosis of congenital cytomegalovirus infection: two decades later. Am J Obstet Gynecol 1990; 163:447.
414 414. Derouin F, Thulliez P, Candolfi E, et al. Early prenatal diagnosis of congenital toxoplasmosis using amniotic fluid samples and tissue culture. Eur J Clin Microbiol Infect Dis 1988; 7:423.
415 415. Leiberman JR, Hagay ZJ, Dagan R. Intraamniotic Haemophilus influenzae infection. Arch Gynecol Obstet 1989; 244:183.
416 416. Zauli DA, de Menezes CL, de Oliveira CL. Development and padronization of three multiplex PCRs for the diagnosis of Chlamydia trachomatis, Toxoplasma gondii, herpes simplex viruses 1 and 2, and cytomegalovirus. Mol Biotechnol 2013; 54:1004.
417 417. Curtin WM, Menegus MA, Patru MM, et al. Midtrimester fetal herpes simplex‐2 diagnosis by serology, culture and quantitative polymerase chain reaction. Fetal Diagn Ther 2013; 33:133.
418 418. Czader M, Post K, Cheng L. Detection of cytomegalovirus infection by quantitative polymerase chain reaction. Methods Mol Biol 2013; 999:257.
419 419. Bourgeois‐Nicolaos N, Cordier AG, Guillet‐Caruba C, et al. Evaluation of the Cepheid Xpert GBS assay for rapid detection of group B streptococci in amniotic fluids from pregnant women with premature rupture of membranes. J Clin Microbiol 2013; 51:1305.
420 420. Bernard B, Barton L, Abate M, et al. Maternal–fetal transfer of cefazolin in the first twenty weeks of pregnancy. J Infect Dis 1977; 136:377.
421 421. Giamarellou H, Gazis J, Petrikkos G, et al. A study of cefoxitin, moxalactam, and ceftazidime kinetics in pregnancy. Am J Obstet Gynecol 1983; 147:914.
422 422. Allegaert K, van Mieghem T, Verbesselt R, et al. Cefazolin pharmacokinetics in maternal plasma and amniotic fluid during pregnancy. Am J Obstet Gynecol 2009; 200:170 e1.
423 423. Atkinson G, Campbell DJ, Cawood ML, et al. Steroids in human intrauterine fluids of early pregnancy. Clin Endocrinol (Oxf) 1996; 44:435.
424 424. Nakanishi T, Suzumori N, Mizuno H, et al. Elevated aldosterone in amniotic fluid and maternal blood has diagnostic potential in pregnancies complicated with a fetus of Bartter syndrome. Fetal Diagn Ther 2005; 20:481.
425 425. Mennuti MT, Wu CH, Mellman WJ, et al. Amniotic fluid testosterone and follicle stimulating hormone levels as indicators of fetal sex during mid‐pregnancy. Am J Med Genet 1977; 1:211.
426 426. Wisniewski L, Jezuita J, Bogoniowska Z, et al. Endokrynologia prenatalna. I. Kortyzol w plynie owodniowym
